1 minute reading time (62 words)

Study Bolsters Patient-Controlled Analgesia for Cancer Pain

AAPM member Kenneth Candido, MD, comments on a study regarding patient-controlled analgesia (PCA) IV hydromorphone titration provides quicker analgesic effect, higher patient satisfaction and a similar tolerability compared with non-PCA administration in patients with severe cancer pain. The findings come from a phase 3, randomized clinical trial involving 214 patients that was presented at the American Society of Clinical Oncology. Read more.

Related Posts

Want more pain resources? Check out our library of on-demand education, upcoming events, and more.

Learn More